|
|
Volumn 4, Issue 5, 2002, Pages 392-398
|
|
HIV1 and the gut in the era of highly active antiretroviral therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AIDS RELATED COMPLEX;
ATYPICAL MYCOBACTERIOSIS;
CYTOMEGALIC INCLUSION BODY DISEASE;
DRUG EFFECT;
ENTEROPATHY;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
MALE;
METHODOLOGY;
MICROBIOLOGY;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
SMALL INTESTINE;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
HIV ENTEROPATHY;
HIV INFECTIONS;
HIV-1;
HUMANS;
INCIDENCE;
INTESTINE, SMALL;
MALE;
MYCOBACTERIUM INFECTIONS, ATYPICAL;
PROGNOSIS;
RISK ASSESSMENT;
|
|
EID: 0036780860
PISSN: 15228037
EISSN: None
Source Type: Journal
DOI: 10.1007/s11894-002-0009-z Document Type: Review |
|
Times cited : (34)
|
|
References (53)
|
